RPSAP66

Across TCGA pan-cancer cohorts, RPSAP66 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPSAP66’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPSAP66 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPSAP66 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

KIRC, STAD, and THCA are the cancer types where RPSAP66 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPSAP66 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.023	.008	2	view →
STAD	Male	II,III,IV	−0.050	.045	1	view →
THCA	Male	All	+0.027	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPSAP66–KIRC

Open the KIRC breakdown →